<DOC>
	<DOCNO>NCT02668991</DOCNO>
	<brief_summary>The purpose study evaluate utility clinically validate Autism Behavior Inventory ( ABI ) measure clinical symptom Autism Spectrum Disorder ( ASD ) compare gold standard measure .</brief_summary>
	<brief_title>Study Assess Janssen Autism Knowledge Engine Participants With Autism Spectrum Disorder Normally Developing Cohort</brief_title>
	<detailed_description>This observational study ( participant identify belong study group assess biomedical health outcome ) evaluate utility Janssen Autism Knowledge Engine ( JAKE ) measure clinical symptom ASD child adult ASD . The study consist 3 cohort participant . For Cohort 1 2 , 14-day Screening phase 8-week ( Cohort 1 ) 10 week ( Cohort 2 ) data collection phase extend Day 0 ( Baseline ) Day 56 Day 70 , respectively . For Cohort 3 , study consist screen visit single test visit , may combine . Primarily , usability JAKE system monitor clinical outcome ASD assess . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<criteria>Cohort 1 2 : Participants must males female age 6 year old least one female every five male participant Diagnosis ASD make confirm use Autism Diagnostic Observation Schedule , 2nd edition ( ADOS2 ) Participants receive behavioral and/or pharmacologic treatment ASD comorbid disorder course study , ( Cohort 1 ) In cohort 2 , part standard care participant must begin behavioral intervention within 2 week Baseline visit Parents legally authorize representative must speak understand English Cohort 3 : Participants must males female age 6 year old least one female every five male participant . Parents legally authorize representative must speak understand English In opinion investigator , subject parent must capable complete procedure task study Each participant legally authorize representative must sign informed consent form ( ICF ) A score normal range Social Communication Questionnaire ( SCQ ) must Diagnostic Statistical Manual Mental Disorders Cohort 1 2 : Measured composite score Kaufmann Brief Intelligence Test2 ( KBIT2 ) less 60 History , current significant medical illness Investigator considers exclude participant Psychological and/or emotional problem would render informed consent invalid limit ability subject comply study requirement Any condition opinion investigator would compromise study , wellbeing subject ; example , visual problem would impede eyetracking view stimuli hearing problem would impede hear auditory stimulus Participant employee investigator study site , direct involvement propose study study direction investigator study site , well family member employee investigator Cohort 3 : History current significant medical illness Investigator considers exclude participant Psychological and/or emotional problem would render informed consent invalid limit ability participant comply study requirement Any condition opinion investigator would compromise study , wellbeing subject ; example , visual problem would impede eyetracking view stimuli hearing problem would impede hear auditory stimulus Participant employee investigator study site , direct involvement propose study study direction investigator study site , well family member employee investigator Participant take sedating medication day test battery consume caffeine within 2 hour prior battery</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Autism Spectrum Disorder</keyword>
	<keyword>Janssen Autism Knowledge Engine</keyword>
	<keyword>Autism Behavior Inventory</keyword>
</DOC>